The global pseudomonas aeruginosa pneumonia drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Pseudomonas is a type of bacteria which is found in the environment, such as in soil and water. Pseudomonas aeruginosa infections occur in people with weakened immune systems or in the hospital where there is a high risk of infection and is risky for patients with chronic lung diseases. The major factor driving the demand for pseudomonas aeruginosa pneumonia drug is the new product launches and drugs approval across the globe.
For instance, in September 2020, Shionogi & Co., Ltd announced the approval of a supplemental New Drug Application (sNDA) for FETROJA (cefiderocol) from the US Food and Drug Administration (FDA). It is used for the treatment of patients 18 years of age or older with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) that is caused by Gram-negative microorganisms. Moreover, North America is expected to hold a prominent share in the market due to the presence of developed and well-structured health care systems and research & development in the region.
To Request a Sample of our Report on Pseudomonas Aeruginosa Pneumonia Drug Market: https://www.omrglobal.com/request-sample/pseudomonas-aeruginosa-pneumonia-drug-market
Some major players in the market include Aridis Pharmaceuticals Inc., and Polyphor Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in April 2021, CARB-X announced that it is funding Phico Therapeutics. The funding was aimed to develop a new intravenous engineered bacteriophage drug for the treatment of ventilator-associated pneumonia caused by drug-resistant Pseudomonas aeruginosa.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Aridis Pharmaceuticals Inc., and Polyphor Ltd., among others.
(Get 15% Discount on Buying this Report)
A full Report of Pseudomonas Aeruginosa Pneumonia Drug Market is Available @ https://www.omrglobal.com/industry-reports/pseudomonas-aeruginosa-pneumonia-drug-market
Global Pseudomonas Aeruginosa Pneumonia Drug Market Report by Segment
By Type
- Aerucin
- EV-035
- MEDI-3902
- Panobacumab
- Others
By Application
- Hospital
- Clinic
- Others
Global Pseudomonas Aeruginosa Pneumonia Drug Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
